Thomas H. Massey

1. Genetic modifiers of Mendelian disease: Huntington’s disease and the trinucleotide repeat disorders
   2017/07/03 by Peter A. Holmans, Peter Holmans, Thomas H. Massey +1 · 1 citation
   Biochemistry, Genetics and Molecular Biology · Neuroscience · #Genetic Neurodegenerative Diseases #Genetics and Neurodevelopmental Disorders #Mitochondrial Function and Pathology
2. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
   2019/08/01 by Jong‐Min Lee, Kevin Correia, Jacob M. Loupe +35 · 2 citations
   Neuroscience · Biochemistry, Genetics and Molecular Biology · #Genetic Neurodegenerative Diseases #Mitochondrial Function and Pathology #DNA Repair Mechanisms
3. Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset
   2022/04/01 by Branduff McAllister, Jasmine Donaldson, Caroline S. Binda +31 · 1 citation
   Neuroscience · Biochemistry, Genetics and Molecular Biology · #Genetic Neurodegenerative Diseases #Mitochondrial Function and Pathology #CRISPR and Genetic Engineering
4. Genetic modifiers of somatic expansion and clinical phenotypes in Huntington’s disease highlight shared and tissue-specific effects
   2025/06/01 by Group 1, Jong-Min Lee, Jong‐Min Lee +43 · 1 citation
   Biochemistry, Genetics and Molecular Biology · Neuroscience · #Genetic Neurodegenerative Diseases #Mitochondrial Function and Pathology #Muscle Physiology and Disorders